COIOSDeep risk insights through multi-disciplinary research across the globe
Item new Peer-reviewed Added

Measles in Italy showed sustained national spread of one D8 strain, 2023 to 2025

Of 1,311 measles cases in Italy, 3.1% were fully vaccinated, and one D8 strain circulated nationally for over 12 months.

This study described measles in Italy from October 2023 to March 2025, using national surveillance data. Virus sequences were classed by genotype and by Distinct Sequence Identifier (DSId), a code naming each distinct strain. There were 1,311 cases in 178 outbreaks, median age 30.9 years, and 38 of 1,230 (3.1%) were fully vaccinated. In 2024 first-dose coverage rose to 94.77%, while second-dose coverage fell to 84.45%. One strain, D8-5963, spread nationally for over 12 months, but no single region had uninterrupted 12-month circulation. The source of infection was unknown in 64.1% of cases, and only 52.8% had a DSId, varying widely by region.

Why it is interesting: One measles strain circulated across Italy for over a year, which the authors read as loss of near-elimination status. Second-dose coverage fell while first-dose coverage rose, and most cases were adults.

Source
Eurosurveillance, 12 November 2026
Paper
Measles resurgence in Italy: analysis of temporal patterns of viral transmission, surveillance performance, and vaccination coverage at national and regional levels, October 2023 to March 2025
Authors
Baccolini V, Sciurti A, Renzi E, Massimi A, Bonanno G, Brunone S et al.
DOI
10.2807/1560-7917.es.2026.31.45.2600090
Type
Peer-reviewed article
Design
National surveillance analysis with molecular (genotype/DSId) typing, 1,311 measles cases and 178 outbreaks, Italy, October 2023–March 2025
Verdict
New finding
Driver
Infection and pandemics
Abstract — the authors' own words, CC BY

BACKGROUNDFollowing substantial progress towards measles elimination after the COVID-19 pandemic, Italy experienced a marked increase in measles cases in 2024.AIMOur aim was to describe measles epidemiology in Italy, October 2023-March 2025, and assess vaccination coverage, surveillance performance at national and regional levels, and temporal patterns of transmission.METHODSNumbers of measles cases and outbreaks were reviewed. Vaccination coverage and surveillance indicators were described at national and regional levels. Measles variants were classified by genotype and Distinct Sequence Identifier (DSId). Temporal transmission patterns of measles variants were assessed nationally and regionally to identify sustained transmission chains (≥ 12 consecutive months).RESULTSIn total, 1,311 measles cases were reported, with 178 outbreaks. Cases' median age was 30.9 years (IQR: 15.6-39.8); 601 were female (45.8%) and 710 male (54.2%). Only 3.1% (38/1,230) were fully vaccinated. In 2024, the first-dose vaccination coverage increased to 94.77% (95% CI: 94.70-94.84%) nationally, while second-dose coverage declined to 84.45% (95% CI: 84.35-84.55%). Among all cases, 12.1% (n = 158) were imported/importation-related, 64.1% (n = 841) were of unknown origin and 52.8% had DSId data available (n = 692), with high regional heterogeneity. Twenty-five measles variants were identified. One variant (D8-5963) showed sustained national transmission for over 12 months, meeting criteria for re-established endemic transmission, although no single region showed uninterrupted ≥ 12-month circulation.CONCLUSIONMeasles resurgence in Italy was marked by persistent immunity gaps, heterogeneous surveillance performance, and sustained national circulation of a D8 variant, indicating loss of near-elimination status. Strengthening vaccination strategies and enhancing molecular surveillance is urgently needed to restore progress towards measles elimination.

Other drivers in Behavioural science